FATIGUE IMPROVEMENT CORRELATES WITH REDUCTIONS IN WORK PRODUCTIVITY IMPAIRMENT AND RELATED INDIRECT COST IN PATIENTS WITH CROHN’S DISEASE: POST HOC ANALYSIS OF PHASE 3 RISANKIZUMAB INDUCTION TRIALS
Edouard Louis 1
Julian Panés 2
Subrata Ghosh 3
Britta Siegmund 4
Wan-Ju Lee 5
Huiwen Deng 6
Kristina Kligys 7
Jasmina Kalabic 8
1 CHU Liège and Liège University, Liège, Belgium
2 Hospital Clínic Barcelona, Barcelona, Spain
3 University College Cork, Birmingham, Ireland
4 Charité - Universitätsmedizin Berlin, Berlin, Germany
5 AbbVie Inc, North Chicago, United States
6 AbbVie Inc., North Chicago, United States
7 AbbVie, North Chicago, United States
8 AbbVie Deutschland GmbH & Co., KG, Ludwigshafen
Conference
UEG Week Vienna 2022
Citation
United European Gastroenterology Journal 2022; 10 (Supplement 8)
Login to access library content
Do you need help setting up your myUEG account?
Contact us at [email protected]